IV Sotalol PO Sotalol p-value
Bradycardia leading to drug discontinuation or dose reduction (n, %) 7 (24.1%) 2 (10.0%) 0.209
QT prolongation leading to drug discontinuation or dose reduction (n, %) 3 (10.3%) 6 (30.0%) 0.081
VT/VF 0 0 -
Average Length of Stay (mean, range) 1.0 (1 - 1) 3.6 (3 - 6) < 0.001